Your browser doesn't support javascript.
loading
Risk factor analysis and nomogram construction of postoperative complications for patients with locally advanced gastric cancer who received neoadjuvant immunotherapy and chemotherapy.
Cui, Hao; Zhang, Sijin; Sun, Linde; Yuan, Zhen; Xu, Qixuan; Gao, Jingwang; Chen, Lin; Cui, Jianxin; Wei, Bo.
Afiliação
  • Cui H; School of Medicine, Nankai University, Tianjin, China.
  • Zhang S; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Sun L; School of Medicine, Nankai University, Tianjin, China.
  • Yuan Z; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xu Q; School of Medicine, Nankai University, Tianjin, China.
  • Gao J; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Chen L; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Cui J; Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Wei B; School of Medicine, Nankai University, Tianjin, China.
Front Med (Lausanne) ; 11: 1405704, 2024.
Article em En | MEDLINE | ID: mdl-39131088
ABSTRACT

Introduction:

The combination of neoadjuvant immunotherapy and chemotherapy (NICT) has become a common treatment regimen for locally advanced gastric cancer (LAGC). However, the safety and efficacy of radical gastrectomy following NICT (NICT-G) remain controversial. This study aimed to analyze the risk factors influencing postoperative complications (POCs) after NICT-G. Additionally, it aimed to construct a nomogram to provide a clinical reference for predicting POCs.

Methods:

This study included 177 patients who received NICT-G at the Chinese PLA General Hospital First Medical Center from January 2020 to January 2024. Univariable and multivariable logistic regression models were used to evaluate the risk factors influencing POCs, and a nomogram model was constructed. To evaluate the discrimination and accuracy of the nomogram model, the area under the receiver operating characteristic curve (AUC) and the calibration curve were measured.

Results:

In 177 patients who received NICT-G, the pathological complete response and major pathological response rates were 15.8% and 45.2%, respectively, whereas the rates of the overall and severe treatment-related adverse events were 71.8% and 15.8%, respectively. In addition, 43 (24.3%) patients developed overall POCs (Clavien-Dindo classification ≥ II). Univariable and multivariable logistic analyses showed that age ≥70 years, greater estimated blood loss, platelet/lymphocyte ratio (PLR) ≤196, neutrophil/lymphocyte ratio (NLR) >1.33, non-R0 resection, and body mass index (BMI) < 18.5 kg/m2 were independent risk factors for overall POCs (p < 0.05). The nomogram model developed using the abovementioned variables showed that the AUC (95% confidence interval [CI]) was 0.808 (95% CI) 0.731-0.885 in predicting the POC risk. The calibration curves showed that the prediction curve of the nomogram was a good fit for the actual POCs (Hosmer-Lemeshow test χ2 = 5.76, P = 0.451).

Conclusion:

The independent risk factors for overall POCs in the NICT-G were age ≥ 70 years, greater estimated blood loss, PLR ≤ 196, NLR > 1.33, non-R0 resection, and BMI < 18.5 kg/m2. The nomogram model developed based on the abovementioned indicators showed better accuracy in predicting the POC risk.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article